According to the State Institute for Drug Control, the domestic drug spending fell by nearly 18% y/y in the 1Q06. Note that the figure was impacted by lowed pharmaceutical margin to 29% from previous 32% as well as uncertainty regarding the drug spending controls proposed by the, at that time, new Minister of Health. We remind that Zentiva’s domestic sales fell in the 1Q06 by 16.6% y/y, which is less than the market. The information has be, however, already announced at Zentiva’s 1Q06 results. The company expects stabilization of the domestic sales in the 2H06 of the year.